Neonc Technologies Holdings Inc (NTHI)

Apr 15, 2025, 8:05 AM EDT - 5 days ago

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

Apr 14, 2025, 8:05 AM EDT - 6 days ago

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

Apr 10, 2025, 8:05 AM EDT - 10 days ago

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President

Apr 8, 2025, 4:05 PM EDT - 12 days ago

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

Mar 31, 2025, 8:05 AM EDT - 20 days ago

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

Mar 27, 2025, 8:05 AM EDT - 24 days ago

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

Mar 25, 2025, 8:45 AM EDT - 26 days ago

NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors

Mar 25, 2025, 8:15 AM EDT - 26 days ago

NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors

Jan 4, 2025, 12:30 AM EST - 3 months ago

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

AERO CAPS CRGT FBGL FLOC INLF INR

Oct 7, 2024, 11:00 AM EDT - 6 months ago

NeOnc Technologies Receives Pharma Tech Outlook's Top Drug Delivery Platform Award for 2024

Aug 5, 2024, 11:00 AM EDT - 9 months ago

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate

Jul 16, 2024, 11:15 AM EDT - 9 months ago

NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation

Jun 26, 2024, 4:39 PM EDT - 10 months ago

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status

May 15, 2024, 11:00 AM EDT - 1 year ago

NeOnc Technologies Wins California Investment Forum's Breakthrough Medical Technology Achievement Award

May 9, 2024, 5:30 PM EDT - 1 year ago

NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10

Mar 30, 2024, 1:00 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

BOLD MMA MNDR NTCL ROTR UBXG WAY

Dec 25, 2023, 9:05 AM EST - 1 year ago

U.S. IPO Weekly Recap: Small Japanese Lists In The US As Insurer Aspen Holdings Joins The IPO Pipeline

LGCB MAMO LZMH

Dec 20, 2023, 2:38 PM EST - 1 year ago

Neonc Technologies Seeks U.S. IPO For Brain Cancer Treatment Pipeline